Skip to main content
Frontiers in Physiology logoLink to Frontiers in Physiology
. 2022 Aug 24;13:1020568. doi: 10.3389/fphys.2022.1020568

Retraction: MiR-22 inhibition alleviates cardiac dysfunction in doxorubicin-induced cardiomyopathy by targeting the sirt1/PGC-1α pathway

Frontiers Editorial Office *
PMCID: PMC9450219  PMID: 36091381

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

Given the concerns, the editors no longer have confidence in the findings presented in the article.

During correspondence, the authors did not respond to the question of whether they agree or disagree to the retraction.

This retraction was approved by the Chief Editors of Frontiers in Physiology and the Chief Executive Editor of Frontiers.


Articles from Frontiers in Physiology are provided here courtesy of Frontiers Media SA

RESOURCES